Rivastigmine Study in Adolescents With Down Syndrome
NCT01084135
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
42
Enrollment
OTHER
Sponsor class
Conditions
Down Syndrome
Interventions
DRUG:
Rivastigmine
OTHER:
Liquid Placebo
Sponsor
Duke University
Collaborators
[object Object]
[object Object]